◀ Back to BCL2
BCL2 — PI3
Text-mined interactions from Literome
Fornoni et al., Am J Pathol 2001
:
The regulation of
Bcl-xL by HGF was
mediated by the
PI3'-K but not by the MEK-1 pathway
van der Kuip et al., Blood 2001
:
The fibronectin mediated antiapoptotic mechanism in Bcr-Abl-active cells was not mediated by overexpression of
Bcl-XL or Bcl-2 but
required an active
phosphatidylinositol 3-kinase (PI-3K)
Ducrey-Rundquist et al., J Virol 2002
:
Furthermore, the
phosphatidylinositol 3-kinase (PI3K) inhibitor wortmannin
blocked IL-7 induced cell survival and
Bcl-2 synthesis but had no effect on the acquisition of HIV susceptibility, suggesting that IL-7 induced HIV type 1 permissiveness is not mediated by the PI-3 K pathway and that, perhaps, the Jak/STAT5 pathway, the other known mediator of IL-7 triggered signaling in T cells, governs this process
Karlsson et al., J Leukoc Biol 2003
:
The addition of LY294002 did not affect the expression of Bcl-2 and Bcl-XL, and thus, we conclude that expression of antiapoptotic
Bcl-2 family member genes is not
dependent on
PI-3 kinase activity
Bae et al., Cancer Res 2006
(Adenocarcinoma...) :
Bcl-w overexpression also
activated phosphoinositide 3-kinase (PI3K) , Akt, and Sp1, and the blocking effects of each of these components using pharmacologic inhibitors, dominant negative mutants, or small interfering RNA abolished the ability of Bcl-w to induce MMP-2 and cell invasion
Liang et al., Nat Cell Biol 2006
(Carcinoma...) :
The autophagic activity of the
Beclin1-PI(3)KC3 complex, however, is
suppressed by
Bcl-2
Creson et al., J Mol Neurosci 2009
(MAP Kinase Signaling System...) :
Evidence for
involvement of ERK,
PI3K , and RSK in induction of
Bcl-2 by valproate
Moriya et al., Hepatology 2012
(Disease Models, Animal...) :
This retained expression of
Bcl-xL is
inhibited by the
phosphatidylinositol 3-kinase (PI3K) inhibitor LY294002